• The IRIS Registry at AAO 2020 Virtual

    What are the latest findings based on IRIS Registry data? Find out during the presentations below, and also in this year’s Original Papers and Scientific Posters.

    How to watch these presentations. Once AAO 2020 Virtual opens on Friday, Nov. 13, log on to the meeting platform at aao.org/2020 and search for the event ID#s listed below. (Note: You will need to be registered for the meeting.)


    Live program: Saturday, 7:00-7:30 a.m. PST (OSO2V)

    Jackson Memorial Lecture: Improving Amblyopia Outcomes Through Clinical Trials and Practice Measurement: Room for Improvement—Michael X. Repka, MD, MBA.

    SUNDAY, NOV. 15

    Live program: Sunday (Sym17)

    Big Data: IRIS Registry and the Bioethics of Big Data in the Next Decade—Michael F. Chiang, MD.

    Presented during 20/20 in Focus: How Technology Will Bring Us Closer to Perfection, (Sunday, Nov. 15, 2:05-2:50 p.m.), a fast-paced symposium with 10 presentations and two Q&A sessions, cosponsored by the Young Ophthalmologist committee.


    The Brolucizumab Experience Thus Far: A Health Economics and Outcomes Research Analysis—Michael S. Ip, MD. Presented during Neovascular AMD, which is part of Retina Subspecialty Day’s on-demand program (Ret15).

    Evaluation of Geographic Atrophy (GA) Secondary to AMD in Real-World Clinical Practice: Analysis of the AAO IRIS Registry—Ehsan Rahimy, MD. Presented during Late-Breaking Developments, Part II, which is part or Retina Subspecialty Day’s on-demand program (Ret16).

    New Insight Into Real-World U.S. Anti-VEGF Injection Data—Stephen D. Schwartz, MD, presented during Medical Retina and Retinal Vascular Disease, which is part of Retina Subspecialty Day’s on-demand program (Ret23).

    Scientific Findings From Big Data From the RPB/AAO Award for IRIS Registry Research—Chair: Michael F. Chiang, MD. On demand (Sym43).

    Four awardees discuss their studies:

    • Infectious and Inflammatory Eye Disease Epidemic Detection and Seasonality—Thomas M. Lietman, MD
    • Characterizing Use of Anti-VEGF Treatment of Diabetic Macular Edema Among Minorities: Bridging the Gap Between Pubich Health and Medicine—Rishi P. Singh, MD
    • Use of Innovative Statistical Methods to Compare Observation With Laser Procedure for Treatment of Central Serous Chorioretinopathy—Subhash Aryal, PhD
    • Cataract Outcomes Among Patients With Uveitis—Jennifer E. Thorne, MD, PhD

    This symposium is cosponsored by the IRIS Registry Executive Committee.


    Industry Showcase: Friday, 9:50-10:20 a.m. PST (ISC03), Saturday, 5:30-6:00 a.m. PST (ISC12), and Sunday, 10:20-10:50 a.m. (ISC69)

    Participating in the IRIS Registry via Verana Health EHR Integration—presented by Verana Health

    Industry Showcase: Saturday, 10:35-11:05 a.m. PST (ISC17) and Saturday, 2:35-3:05 p.m. PST (ISC22)

    New Findings From the IRIS Registry: Evaluating Geographic Atrophy in Real-World Clinical Practice—presented by Apellis Pharmaceuticals

    Industry Showcase: Sunday, 9:40-10:10 a.m. PST (ISC68) and Sunday, 2:05-2:35 p.m. (ISC72)  

    Geographic Atrophy: New Findings From the IRIS Registry and the Role of Complement System in GA—presented by Apellis Pharmaceuticals